iSonea Ltd. (KSL) is the parent company of both iSonea (Israel) Ltd. (KSI), from Haifa, Israel and PulmoSonix Pty. Ltd. (KSA) from Victoria, Australia. KSL fully owns KSI and KSA and is traded on The Australian Stock Exchange (ASX) under the KSX symbol. KSL, KSA and KSI have the same Board of Directors with Mr. Peter Marks of Melbourne, Australia serving as Chairman, and Dr. Nathan Intrator of Haifa, Israel serving as and Executive Director and CEO of iSonea Ltd. in Israel. The Australian and the Israeli subsidiaries are both focused on pulmonary acoustics as diagnostic and monitoring tools for managing Asthma and other pulmonary disorders.